INTRODUCTION
Cyclophosphamide (CYC) and azathioprine (AZA) have been used clinically as immunosuppressive agents for the treatment of certain nephrotic syndromes and immunologic diseases of children, notwithstanding their mutagenic and teratogenic potential. But it may be the present state that the agents are used reluctantly because of few effective drugs to these diseases. In our clinic, for the purpose of reducing the several side-effects of CYC for the treatment of nephrotic children, a protein-bound polysaccharide, PS-K, isolated from Basidiomycetes (Tsukagoshi, 1974) , has been successfully used.
The purpose of the present investigation is to study the cytogenetic effect, as revealed by the SCE test, of immunosuppressive agents, AZA and CYC, and of CYC combined with PS-K.
MATERIALS AND METHODS
The non-treated control group included 20 normal healthy children (10 males, 10 females, age: 6-15-years-old), who had no history of medication, X-ray exposures, or any significant viral disease, at least for the last six months. As indicated in Table 1 , the same number of treated-children were examined (9 males, 11 females, age: 5-14-years-old): the AZA group (cases 1-3) had taken in most occasions, 1 mg/kg/day AZA for 8-47 weeks; CYC group (cases 4-11), 1 mg/kg/day CYC for 4-20 weeks; CYC plus AZA group (cases 12-13), the same doses as above for 5-7 weeks; and CYC plus PS-K group (cases 14-20), 3 g orally/day PS-K and 1 rag/ kg/day CYC for 4-28 weeks. There were 12 cases of nephrotic syndrome, 5 cases of nephritis, and 1 each of progressive systemic sclerosis, systemic lupus erythematosus, and juvenile rheumatoid arthritis.
Blood samples were obtained from the patients 4-5 hours after taking of the agents. Peripheral lymphocytes from each of the controls and the patients were cultured in the Gibco chromosome medium containing 5-bromo-2'-deoxyuridine (BUdR, 30 ~g/ml), at 37~ for 72 hours in complete darkness. Two hours before harvest, cultures were treated with 0.4 ;g/ml of colcemid followed by hypotonic treatment (0.075 M KC1, 12 min), fixed in 3 : 1 methanol-acetic acid, and air-dried on slide. The slides were mounted with SSrensen buffer (pH 7.0) for 15 min, stained successively with Hoechst 33258 (1.0 ;g/ml in the same buffer) for 12 min, and rinsed briefly in the buffer. They were mounted in the buffer under a coverslip and placed in a petri dish. Photosensitization was done at a distance of 10 cm from the source of 200 W mercury arc lamp for 15 min. The slides were incubated for 15-30 min in 2 x SSC at 60~ followed by 30-rain staining in 3~o Giemsa solution (Giemsa staining buffer, pH 6.8). For each culture 9-40 well-spread metaphases were selected under 1,000 x magnification and examined for SCEs.
RESULTS
In the control group, a total of 500 cells were analyzed for the frequency of SCEs (Table 1 ). The mean frequency was 5.63+0.587 SCEs per cell (mean+SD), with a range from 3.61 to 7.76. The frequency in the AZA group ranged from 11.27 to 12.24, with a mean value of 11.70. The frequency in CYC group ranged from 10.20 to 18.03, with a mean value of 15.10_+2.431. A highly significant increase was observed in CYC group. The CYC plus AZA group showed an even higher value (19.52). The frequency in CYC plus PS-K group ranged from 6.24 to 12.44, with a mean value 9.16+2.225. Figure 1 shows the relation between frequency of SCEs and medication term in these four groups. It was found that the SCE frequency in the CYC plus PS-K group was lower than that in other groups at any time of medication. And it ap- peared that the frequency of SCEs was not medication term-dependent in these four groups, when each immunosuppressive agent was prescribed with uniform doses such as 1 mg/kg/day.
As seen in Fig. 2 , high frequency of SCEs which was detectable duringthe treatment of CYC medication returned to almost normal levels at 3-4 months 'after the cessation of CYC medication.
DISCUSSION
Recently, undesirable side-effects of immunosuppressive agents have been reported by several authors, and attention has been called to higher risk of malignant disease (Wegmann et aL, 1971; Manny et aL, 1972) . Mutagenic effects of CYC, especially on chromosomal aberrations, have been studied in patients with malignant tumors and other diseases (Vormittag, 1974; Dobos et aL, 1974) . AZA is also known to induce chromosome aberrations (Zeuthen and Friedrich, 1971; Ganner et al., 1973) . Furthermore, possible teratogenicity of CYC and AZA have been reported (Chaube and Murphy, 1968; Cahen, 1966; Rosenkrantz et al., 1967; Tallent et al., 1970; Greenberg and Tanaka, 1964) .
The clastogenic effects of these immunosuppressive agents have been studied mostly in patients with malignant tumors or those operated upon organ transplantation. However, little work has been done on the effects upon SCEs of nontumorous children. In this investigation, the frequency of SCEs in children treated with immunosuppressive agents increased in the following sequence: AZA group, CYC group, and CYC plus AZA group. It seems that the extremely high value observed in the last group is due to the summation or potentiation of the effects exerted by the two agents. A similar result was obtained from a nephrotic child treated with CYC and anticonvulsant drugs (Torigoe, 1979) . In all cases dealt in the present study, prednisolone (PRE) or indomethacine (IND) was used in combination with immunosuppressive agents. A question may arise as to whether PRE or IND has influence on the frequency of SCEs or not. Since the cessation of only CYC medication caused the reduction of SCEs to normal level, it is supposed that PRE and IND have no effect on the frequency of SCEs.
PS-K was found to possess an antitumor activity against several experimental tumors, restoring the suppressed delayed-type hypersensitivity reaction in tumorbearing animals to the normal levels, stimulating humoral immunity in experimental animal, and having a mitogenic effect on human lymphocytes in vitro (Tsukagoshi and Ohashi, 1974; Usui et aL, 1976; Nomoto et aL, 1975; Nakao et aL, 1973; Ohono et aL, 1976) . This drug was found to have no teratogenic activity nor significant side effect on offsprings of rodent species (Seto et aL, 1975a, b) . No abnormality of chromosomes caused by PS-K was found in mouse bone marrow cells in vivo and in vitro (Kureha Chemical Industry, 1977) . In the present study the frequency of SCEs decreased markedly, when PS-K was combined with CYC. A similar result was obtained in bone marrow cells of ddY mice (Torigoe et aL, unpublished data) . It is known that mutagen increases the frequency of SCEs (Perry and Evans, 1975) . It may not be always true that reduction of SCEs means decrease in mutagenicity. Though there are no data available at present to clarify the mechanism is involved in the effect of PS-K, it is possible that PS-K may reduce a mutagenicity afforded by treatment with CYC.
